Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Revance Therapeutics (RVNC) Insider Trading & Ownership

Revance Therapeutics logo

Revance Therapeutics (NASDAQ:RVNC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.10%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
6
Amount Of
Insider Selling
(Last 3 Years)
$7.03M
Get RVNC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RVNC Insider Buying and Selling by Quarter

Revance Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/16/2024
Erica Jordan
Insider
Sell2,392$3.80$9,089.60  
3/18/2024
Dustin S Sjuts
President
Sell9,211$5.04$46,423.44  
3/18/2024Sell8,125$5.04$40,950.00  
3/18/2024Sell9,361$5.04$47,179.44  
10/4/2023
Thomas R. Carper
Thomas R. Carper
Senate (D-DE)
Buy$10.55$1,001 - $15,000
9/5/2023Sell23,853$17.81$424,821.93  
8/3/2023Sell26,279$22.57$593,117.03  
7/3/2023Sell26,279$24.94$655,398.26  
7/3/2023Sell1,701$25.04$42,593.04  
6/15/2023Sell2,500$28.24$70,600.00  
6/9/2023
Dustin S Sjuts
President
Sell5,000$30.82$154,100.00  
6/9/2023Sell31,279$30.72$960,890.88  
6/1/2023Sell2,701$30.57$82,569.57  
5/15/2023
Dustin S Sjuts
President
Sell21,015$34.55$726,068.25  
5/15/2023Sell21,401$34.55$739,404.55  
5/15/2023Sell70,447$34.55$2,433,943.85  
(Data available from 1/1/2013 forward)

RVNC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Revance Therapeutics includes Carey Oconnor Kolaja, Dustin S Sjuts, Dwight Moxie, Erica Jordan, Mark J Foley, and Tobin Schilke. Learn more on insiders at RVNC.

5.10% of Revance Therapeutics stock is owned by insiders. Learn more on RVNC's insider holdings.



This page (NASDAQ:RVNC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners